Bridgehead International is a leading biopharmaceutical consultancy group, offering a range of services designed to assist clients in achieving extraordinary growth across the product and technology value chain. Bridgehead provides a unique mix of scientific, technical, intellectual property and business consultants experienced in the areas of product strategy, market access, business development, due diligence and valuation. Bridgehead has completed over 300 projects for clients in biotechnology, pharmaceutical, medical devices and diagnostic sectors.
Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries. The firm's clients include most of the world's top 20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, and Sales. From its locations in Raleigh, N.C., Parsippany, N.J., Los Angeles, San Francisco, Chicago, Boston, Philadelphia, and New York City, the firm serves clients throughout North America, Europe, and Japan.
Covance Market Access Services is the premier provider of economic marketing and patient support services to the pharmaceutical, biotechnology, and medical device industries.
Covance’s consulting services help identify, build, and sustain a product's advantage in the marketplace. Our multimedia contact center programs improve patient access, retention, and loyalty, and help secure rapid market acceptance.
With our unique experience, depth of expertise, and dedication to service, Covance can deliver what you need: results that make the difference between potential and success.
Pharmaceutical and biotech manufacturers rely on Express Scripts' HealthBridge Pharma & Biotech℠ suite of integrated service offerings committed to the seamless patient journey. We optimize market insight, leading technology and consolidated data to provide customized, integrated business solutions while never losing sight of the patient. Our innovative new service models and single point of contact ease the commercialization process and enhance return on investment for our pharmaceutical manufacturer clients.
MME is a global leader in the development of value-based strategies and market research for health care goods and services. We are driven by intellectual curiosity and passionate about solving complex problems.
Our value-based solutions provide our clients with unique guidance and insights for their pricing and marketing strategies and tactics. We help clients identify, frame, capture, and communicate their products value.
Our motto is our promise: Learn From Our Experience, Profit From Our Thinking.®
The Online Master of Science in Pharmacy program at University of Florida offers expertise and credentials in non-dispensing areas of pharmacy including Regulation, Policy, Patient Safety & Risk Management, Applied Pharmacoeconomics and more, including a UF-MSPharm / Stetson University-MBA option.
Courses for this 30-credit program are taken live, online in highly-interactive virtual classrooms. Students take one 7-week class at a time, with each class meeting twice per week (Sunday through Thursday) during evening hours to accommodate professional, working students. This non-thesis, part time program can be completed in as little as two years. And, through a partnership with Stetson University, each institution accepts 6 credits from the other, allowing students to complete both the UF-MSPharm and the Stetson-MBA degrees in as little as three years. Prospective applicants should have a minimum 3.0 GPA and GRE scores of 500/500, though the GRE is waived for those holding advanced degrees.
Completed applications can be processed in as little as two weeks. Apply by November 15 for spring admission.
Xcenda is a leading full-service consultancy and managed markets agency composed of experienced marketers, health outcomes researchers, reimbursement strategists, and market research experts. We help pharmaceutical, biotech, and medical device companies quantify, validate, and communicate the clinical and economic value of their products. Xcenda partners with manufacturers to maximize patient access and optimize commercial success across all phases of the product life cycle. As an AmerisourceBergen Specialty Group company, our clients benefit from significantly greater access to the resources and strategic relationships required to successfully commercialize products within the oncology and specialty market. Xcenda’s team delivers the unique combination of strategic insight and field support that manufacturers require to develop and implement integrated, data-focused, and value-driven commercial strategies.